Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $105.33

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $105.3333.

Several brokerages have issued reports on USPH. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. Barrington Research reiterated an “outperform” rating and set a $103.00 price target on shares of U.S. Physical Therapy in a report on Friday. JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds have recently made changes to their positions in the stock. Envestnet Asset Management Inc. boosted its stake in U.S. Physical Therapy by 9.4% during the second quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock worth $27,070,000 after acquiring an additional 29,671 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of U.S. Physical Therapy during the third quarter valued at about $845,000. Geode Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 1.2% during the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after purchasing an additional 4,306 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of U.S. Physical Therapy by 4.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock worth $10,288,000 after purchasing an additional 6,190 shares in the last quarter. Finally, CenterBook Partners LP grew its stake in shares of U.S. Physical Therapy by 189.0% in the 2nd quarter. CenterBook Partners LP now owns 47,014 shares of the company’s stock valued at $3,676,000 after buying an additional 30,746 shares during the period.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $85.08 on Monday. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of 35.75, a PEG ratio of 3.51 and a beta of 1.30. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30. The business’s 50-day moving average price is $83.30 and its 200-day moving average price is $82.61. U.S. Physical Therapy has a 12 month low of $62.77 and a 12 month high of $93.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.